| TGFBR1 |
TGFBR1: TGF-beta receptor type-1 precursor |
YBX1 |
YBX1, NSEP1, YB1: Nuclease sensitive element-binding protein 1 |
1.142 |
Evidence |
|
| TACR2 |
TACR2, NK2R, NKNAR, TAC2R: Substance-K receptor |
GSK3A |
GSK3A: Glycogen synthase kinase-3 alpha |
1.142 |
Evidence |
|
| SMAD2 |
SMAD2, MADH2, MADR2: Mothers against decapentaplegic homolog 2 |
FKBP8 |
DKFZp686M22160: Putative uncharacterized protein DKFZp686M22160 (Fragment) |
1.142 |
Evidence |
|
| INSR |
INSR: Insulin receptor precursor |
CDK2 |
CDK2: Cell division protein kinase 2 |
1.142 |
Evidence |
|
| KPNA2 |
KPNA2, RCH1, SRP1: Importin subunit alpha-2 |
MLL |
MLL, ALL1, HRX, HTRX, TRX1: Zinc finger protein HRX |
1.142 |
Evidence |
|
| DUSP1 |
DUSP1, CL100, MKP1, PTPN10, VH1: Dual specificity protein phosphatase 1 |
PTPN11 |
IPI00298347 |
1.142 |
Evidence |
|
| MYF5 |
MYF5: Myogenic factor 5 |
HSP90AA1 |
Hsp89-alpha-delta-N |
1.142 |
Evidence |
|
| RELA |
RELA, NFKB3: Transcription factor p65 |
HSP90AA1 |
Hsp89-alpha-delta-N |
1.142 |
Evidence |
|
| GRIA1 |
GRIA1, GLUH1, GLUR1: Glutamate receptor 1 precursor |
FKBP4 |
FKBP4: FK506-binding protein 4 |
1.142 |
Evidence |
|
| APC |
IPI00215877 |
CBLB |
CBLB, RNF56, Nbla00127: E3 ubiquitin-protein ligase CBL-B |
1.142 |
Evidence |
|
| PCAF |
PCAF: Histone acetyltransferase PCAF |
PSMA3 |
PSMA3, PSC8: Proteasome subunit alpha type-3 |
1.142 |
Evidence |
|
| INSR |
INSR: Insulin receptor precursor |
GSK3A |
GSK3A: Glycogen synthase kinase-3 alpha |
1.142 |
Evidence |
|
| LPHN1 |
LPHN1, KIAA0821, LEC2: Latrophilin-1 precursor |
GHRH |
GHRH, GHRF: Somatoliberin precursor |
1.142 |
Evidence |
|
| GHRH |
GHRH, GHRF: Somatoliberin precursor |
SCTR |
SCTR: Secretin receptor precursor |
1.142 |
Evidence |
|
| RAMP3 |
RAMP3: Receptor activity-modifying protein 3 precursor |
CALCA |
CALCA, CALC1: Calcitonin precursor [Contains: Calcitonin; Katacalcin |
1.142 |
Evidence |
|
| RAMP3 |
RAMP3: Receptor activity-modifying protein 3 precursor |
CALCB |
CALCB, CALC2: Calcitonin gene-related peptide 2 precursor |
1.142 |
Evidence |
|
| PRKACG |
PRKACG: cAMP-dependent protein kinase, gamma-catalytic subunit |
KCNJ2 |
KCNJ2, HIRK1: Inward rectifier potassium channel 2 |
1.142 |
Evidence |
|
| KCNJ5 |
KCNJ5, GIRK4: G protein-activated inward rectifier potassium channel 4 |
PRKX |
PRKX, PKX1: Serine/threonine-protein kinase PRKX |
1.142 |
Evidence |
|
| PPP2CB |
PPP2CB: Serine/threonine-protein phosphatase 2A catalytic subunit beta isoform |
RELB |
RELB: Transcription factor RelB |
1.142 |
Evidence |
|
| LIN7A |
LIN7A, MALS1, VELI1: Lin-7 homolog A |
HTR2A |
HTR2A, HTR2: 5-hydroxytryptamine receptor 2A |
1.142 |
Evidence |
|
| HPN |
HPN, TMPRSS1: Serine protease hepsin |
ITIH4 |
ITIH4, IHRP, PRO1851, ITIHL1, PK120: Inter-alpha-trypsin inhibitor heavy chain H |
1.142 |
Evidence |
|
| CD33 |
CD33, SIGLEC3: Myeloid cell surface antigen CD33 precursor |
CFP |
CFP, PFC: Properdin precursor |
1.142 |
Evidence |
|
| TAL1 |
TAL1, SCL, TCL5: T-cell acute lymphocytic leukemia protein 1 |
SPTA1 |
SPTA1, SPTA: Spectrin alpha chain, erythrocyte |
1.142 |
Evidence |
|
| TLR2 |
TLR2, TIL4: Toll-like receptor 2 precursor |
RGS2 |
RGS2, G0S8: Regulator of G-protein signaling 2 |
1.142 |
Evidence |
|
| SLC4A1 |
SLC4A1, AE1, DI, EPB3: Band 3 anion transport protein |
MAP2K3 |
MAP2K3, MEK3, MKK3, PRKMK3: Dual specificity mitogen-activated protein kinase ki |
1.142 |
Evidence |
|